Winner of the 2024 LuminaX Accelerator, Bloody Good Tests is redefining diagnostics with a direct-to-consumer platform offering blood, DNA, gut microbiome testing – and soon, full-body MRIs.
Founded by Thor Berg and Ben Novakovic, BGT empowers Australians to take control of their health with instant online referrals, access to over 4,000 collection centres, and even mobile phlebotomy visits to homes, offices, or gyms. Results are delivered via a sleek app in clear, everyday language.
Since joining LuminaX, the startup has rapidly scaled – tripling its team, refining its strategy, and attracting key investors met through the program, including Go1 co-founders Andrew Barnes and Dr Vu Tran. Vu has since joined BGT as a co-founder and Chief Medical Officer.
With 10,000+ tests completed and partnerships with NutriPATH and Healius, BGT is not only serving consumers but also powering diagnostics infrastructure for health practitioners and startups via its API.
Now headquartered at Cohort, BGT is gearing up for major commercial partnerships and long-term growth – making preventative health accessible, empowering, and bloody good.
END.
